New HIV drug trial halted early – what happened?

NCT ID NCT06061081

Terminated Disease control Sponsor: ViiV Healthcare Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an experimental HIV drug called VH3739937 in 21 adults with HIV who had never taken HIV medication before. The goal was to see how well the drug lowered the virus level in the blood over a short time. The trial was stopped early, and results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV INFECTIONS

Contacts and locations

Locations

GSK Investigational Site

Bakersfield, California, 93301, United States
GSK Investigational Site

Miami, Florida, 33136, United States
GSK Investigational Site

Dallas, Texas, 75246, United States
GSK Investigational Site

Buenos Aires, C1181ACH, Argentina
GSK Investigational Site

Rosario, 2000, Argentina
GSK Investigational Site

Athens, 12462, Greece
GSK Investigational Site

Brescia, 25123, Italy
GSK Investigational Site

Genova, 16132, Italy
GSK Investigational Site

Milan, 20142, Italy
GSK Investigational Site

Roma, 00133, Italy
GSK Investigational Site

Warsaw, 01-201, Poland
GSK Investigational Site

A Coruña, 15006, Spain
GSK Investigational Site

Alicante, 03010, Spain
GSK Investigational Site

Granada, 18014, Spain
GSK Investigational Site

Jerez de la Frontera, 11407, Spain
GSK Investigational Site

Madrid, 28006, Spain
GSK Investigational Site

Madrid, 28222, Spain
GSK Investigational Site

Vitoria-Gasteiz, 1009, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.